Primary Care Rebates

The request was successful.

Dear NHS Calderdale Clinical Commissioning Group,

I would like to request the following information with regards to primary rebates schemes that have been signed by your CCG/ Board in the past 12 months.

1. Are there any signed for any of the following products, and if so , which ones:

Insulins (basal, bolus and premix)
GLP-1 (i.e Trulicity)
DPP-IV (i.e Januvia or Onglyza)
SGLT-2 (I.e Invokana)
Growth Hormones (norditropin; omnitrope; Genotropin; humatrope; nutropinAq; Saizen)

2. What are the start and finish dates (or ongoing if open ended)?

3. Which rebates are independent? or are they aligned to PrescQIPP?

4. What is the total number of primary rebate schemes (any included) that your CCG/ Board has signed?

Thank you for taking the time to answer these questions.

Yours faithfully,

Oliver Caswell

FOI.CALDERDALE (NHS CALDERDALE CCG),

Dear Oliver

 

FOI Ref: 2122164

 

Thank you for your application for information under the Freedom of
Information Act 2000 received on 26 January 2022.

 

We are looking into your request and will respond to you within the 20
working day deadline.  The response due date for your request is 23
February 2022.

 

Under the Freedom of Information Act your request may be subject to one or
more exemptions which the CCG is entitled to apply in order to refuse your
request, either wholly or in part.  In some circumstances, once the
information has been identified, the CCG may also levy a fee for
processing and delivering the information to you.  In such circumstances
we will notify you as soon as possible of exemptions which may apply or
any fees to be charged.

 

Please note that if we are having any difficulties retrieving the
information you have requested we will let you know.

 

If you require any further assistance with handling this request, then
please do not hesitate to contact us quoting the FOI Ref shown above by
email: [1][Calderdale CCG request email].

 

Kind regards

 

Brenda

 

Brenda Powell | Corporate and Governance Senior Officer

NHS Calderdale Clinical Commissioning Group |2^nd Floor, Westgate House,
Westgate, Halifax HX1 1PS | Tel: Currently working at home – no access to
a phone | Email: [2][email address]

 

NHS CALDERDALE CCG DISCLAIMER

This is an email from Calderdale Clinical Commissioning Group (CCG). This
message and any files transmitted with it are confidential. If you are not
the intended recipient any reading, printing, storage, disclosure, copying
or any other action taken in respect of the e-mail is prohibited and may
be unlawful. If you have received this message in error, please notify the
sender immediately by using the reply function and then delete what you
have received. Calderdale CCG accepts no responsibility for any changes
made to this message after the original author has sent it. The views or
opinions contained herein do not necessarily represent the views of
Calderdale CCG. This e-mail or any of its attachments may contain data
that falls within the scope of the Data Protection Acts and the Freedom of
Information Act. You must ensure that any handling or processing of such
data by you is fully compliant with the terms and provisions of the Data
Protection Act 1984 and 1998 and Freedom of Information Act 2000

 

 

show quoted sections

FOI.CALDERDALE (NHS CALDERDALE CCG),

1 Attachment

Dear Oliver,

Please find attached NHS Calderdale CCG's response to your Freedom of Information request.

Kind regards,

Debbie Mitchell - Corporate Support Officer
PA to Dr Steven Cleasby – Chair of CCG

NHS Calderdale Clinical Commissioning Group (CCG)
2nd Floor, Westgate House, Westgate, Halifax HX1 1PW

Email: [email address]
Tel: 01422 307400
[mobile number]

NHS CALDERDALE CCG DISCLAIMER
This is an email from Calderdale Clinical Commissioning Group (CCG). This message and any files transmitted with it are confidential. If you are not the intended recipient any reading, printing, storage, disclosure, copying or any other action taken in respect of the e-mail is prohibited and may be unlawful. If you have received this message in error, please notify the sender immediately by using the reply function and then delete what you have received. Calderdale CCG accepts no responsibility for any changes made to this message after the original author has sent it. The views or opinions contained herein do not necessarily represent the views of Calderdale CCG. This e-mail or any of its attachments may contain data that falls within the scope of the Data Protection Acts and the Freedom of Information Act. You must ensure that any handling or processing of such data by you is fully compliant with the terms and provisions of the Data Protection Act 1984 and 1998 and Freedom of Information Act 2000

show quoted sections